Search - tctmd.com

Displaying 841 - 860 of 1248

Sort: Relevancy | Date

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Daily News

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Caitlin E. Cox

June 25, 2018

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Caitlin E. Cox

May 09, 2018

Presentation EAS 2018

Stress, Behavior and Cardiovascular Disease

Presenter: Viola Vaccarino

May 06, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

Advertisement

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

New Review Probes Possibility of CVD Prevention Without Aspirin

Once Again, ISCHEMIA Trial Feels the Squeeze

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Stress, Behavior and Cardiovascular Disease

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content